← Back to Search

Other

Low Glycemic Index Diet Group for Epilepsy

N/A
Waitlist Available
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of focal or generalized epilepsy as defined by the International League Against Epilepsy
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during the intervention until 3 months postpartum
Awards & highlights

Study Summary

This trial studies how a low glycemic diet affects pregnant people with epilepsy, examining how it affects their seizures, tolerance, and gut bacteria.

Who is the study for?
This trial is for pregnant individuals with epilepsy. Participants will be following a low glycemic index diet and providing stool and blood samples up to three times during the study. The trial excludes those not willing to adhere to the dietary plan or unable to provide samples as required.Check my eligibility
What is being tested?
Researchers are testing if a low glycemic index diet is tolerable, can change seizure frequency, and affect gut bacteria in pregnant people with epilepsy. They'll compare results from participants on this diet against those who aren't following any structured diet plan.See study design
What are the potential side effects?
Potential side effects of a low glycemic index diet may include changes in bowel habits, such as constipation or diarrhea, possible nutrient deficiencies if not properly managed, and hypoglycemia (low blood sugar levels).

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with epilepsy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the intervention until 3 months postpartum
This trial's timeline: 3 weeks for screening, Varies for treatment, and during the intervention until 3 months postpartum for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Tolerability of the low glycemic index diet in pregnant people with epilepsy
Secondary outcome measures
Gut Bacteria Composition
Metabolic pathway alterations
Seizure Frequency

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Low Glycemic Index Diet GroupExperimental Treatment1 Intervention
A low glycemic index diet will be started with ongoing dietician support & food questionnaires until pregnancy completion.
Group II: Standard Diet GroupActive Control1 Intervention
A standard diet, as chosen by participants, will be followed with ongoing food questionnaires until pregnancy completion.

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,622 Previous Clinical Trials
11,468,736 Total Patients Enrolled
11 Trials studying Epilepsy
54,292 Patients Enrolled for Epilepsy
Epilepsy FoundationOTHER
10 Previous Clinical Trials
394 Total Patients Enrolled
8 Trials studying Epilepsy
351 Patients Enrolled for Epilepsy
~14 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top